近日,美通社PR Newswire发布,方达美国总部位于宾夕法尼亚州Exton的CDMO GMP生产基地已于2025年10月顺利完成GMP验证,并正式进入全面运营阶段。该基地此前已于2025年5月完成建设并启用,本次验证完成标志着工厂正式具备稳定、合规、可持续交付的生产能力。目前,该4300平GMP设施已可支持III期临床批次生产、工艺验证批(PPQ)以及小规模商业化生产,覆盖无菌制剂、半固体、...
Source Link近日,美通社PR Newswire发布,方达美国总部位于宾夕法尼亚州Exton的CDMO GMP生产基地已于2025年10月顺利完成GMP验证,并正式进入全面运营阶段。该基地此前已于2025年5月完成建设并启用,本次验证完成标志着工厂正式具备稳定、合规、可持续交付的生产能力。目前,该4300平GMP设施已可支持III期临床批次生产、工艺验证批(PPQ)以及小规模商业化生产,覆盖无菌制剂、半固体、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.